Pharmaceutical industry articulates its strategy to compete with the tobacco industrySmoking bans, or as activists refer to them, "public policy changes" are the integral tactic to level the marketplace playing field.
Here is the article that started pharmaceutical nicotine's targeted fight against big tobacco....for profit...not health.
A Reflection On Alternative Nicotine Delivery Systems
Mark C. Taylor, MD,. FRCSC
Physicians for a Smoke-Free Canada (circa 1997?)
Article source: http://www.smoke-free.ca/pdf_1/ands.pdf
AND=Alternative nicotine delivery
......a quote from the article in page one second paragraph:
"....The proper regulatory response is to implement a strategy that levels the regulatory playing field between the cigarette and AND products.
"..Pharmaceutical companies are urged to be more aggressive marketers. "I think it important that nicotine drug manufacturers (Johnson & Johnson, RWJF), who will profit from less cigarette sales, pursue this in their advertising and that they lift any voluntary restraints they have from directly competing with tobacco products and attacking the tobacco industry."
This is the smoking gun which exposes the internal strategies of the pharmaceutical nicotine industry; and the real justification for smoking bans, - it's profit... pure and simple.
Meanwhile, here is the proper way to deal with secondhand smoke; which should be regulated, not banned. Regulations and air quality safety standards are the manner in which we deal with all other workplace hazards, so why be more selective regarding secondhand smoke.......unless there is an underlying agenda.